{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:56:48Z","timestamp":1740149808375,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12328-019-01016-3","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T06:49:23Z","timestamp":1562741363000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A case of suspected portal-pulmonary hypertension due to hepatitis C virus infection"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-5977","authenticated-orcid":false,"given":"Akio","family":"Miyasaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"1016_CR1","doi-asserted-by":"publisher","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","volume":"62","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonaly hypertension. J Am Coll Cardiol. 2013;62:D42\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"1016_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e9","year":"2016","unstructured":"Gali\u00e9 N, Humbert M, Vachiery JL, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Pediatrics and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67\u2013119.","journal-title":"Eur Heart J"},{"key":"1016_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","volume":"144","author":"A Berzigotti","year":"2013","unstructured":"Berzigotti A, Seijo S, Arena U, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2013;144:102\u201311.","journal-title":"Gastroenterology"},{"key":"1016_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/hep.1840120417","volume":"12","author":"K Kimura","year":"1990","unstructured":"Kimura K, Ohto M, Matsutani S, et al. Relative frequencies of portosystemic pathways and renal shunt formation through the \u201cposterior\u201d gastric vein: portographic study in 460 patients. Hepatology. 1990;12:725\u20138.","journal-title":"Hepatology"},{"key":"1016_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/etm.2013.918","volume":"5","author":"HS Chen","year":"2013","unstructured":"Chen HS, Xing SR, Xu WG, et al. Portopulmonary hypertension in cirrhotic patients: prevalence, clinical features and risk factors. Exp Ther Med. 2013;5:819\u201324.","journal-title":"Exp Ther Med"},{"key":"1016_CR6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.110.963314","volume":"123","author":"R Paulin","year":"2011","unstructured":"Paulin R, Courboulin A, Meloche J, et al. Signal transducers and activators of transcription-3\/pim 1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation. 2011;123:1205\u201315.","journal-title":"Circulation"},{"key":"1016_CR7","doi-asserted-by":"publisher","first-page":"9599","DOI":"10.1073\/pnas.171311298","volume":"98","author":"G Gong","year":"2001","unstructured":"Gong G, Waris G, Tanveer R, et al. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA. 2001;98:9599\u2013604.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1016_CR8","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s10620-010-1220-7","volume":"55","author":"S Dhillon","year":"2010","unstructured":"Dhillon S, Kaker A, Dosanjh A, et al. Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C. Dig Dis Sci. 2010;55:1785\u201390.","journal-title":"Dig Dis Sci"},{"key":"1016_CR9","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00380-015-0701-1","volume":"31","author":"T Ko","year":"2016","unstructured":"Ko T, Hatano M, Nitta D, et al. A case of interferon-\u03b1-induced pulmonary arterial hypertension after living donor liver transplantation. Heart Vessels. 2016;31:1206\u20138.","journal-title":"Heart Vessels"},{"key":"1016_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2169\/internalmedicine.56.7822","volume":"56","author":"H Tsuchiya","year":"2017","unstructured":"Tsuchiya H, Kioka H, Ozu K, et al. Interferon therapy exacerbated pulmonary hypertension in a patient with hepatitis C virus infection: pathogenic interplay among multiple risk factors. Intern Med. 2017;56:1061\u20135.","journal-title":"Intern Med"},{"key":"1016_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4103\/2045-8932.105039","volume":"2","author":"PM George","year":"2012","unstructured":"George PM, Cunningham ME, Galloway-Phillipps N, et al. Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity. Pulm Circ. 2012;2:501\u20134.","journal-title":"Pulm Circ"},{"key":"1016_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.114.302221","volume":"114","author":"PM George","year":"2014","unstructured":"George PM, Oliver E, Dorfmuller P, et al. Evidence for the involvement of type I interferon in pulmonary hypertension. Circ Res. 2014;114:677\u201388.","journal-title":"Circ Res"},{"key":"1016_CR13","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.chest.2015.09.018","volume":"149","author":"S Renard","year":"2016","unstructured":"Renard S, Borentain P, Salaun E, et al. Severe pulmonary arterial hypertension in patients treated for hepatitis C with sofosbuvir. Chest. 2016;149:e69\u201373.","journal-title":"Chest"},{"key":"1016_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00535-017-1391-5","volume":"53","author":"K Chayama","year":"2018","unstructured":"Chayama K, Suzuki F, Karino Y, et al. Efficacy and safety of glecaprevir\/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis. J Gastroenterol. 2018;53:557\u201365.","journal-title":"J Gastroenterol"},{"key":"1016_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29510","author":"H Toyoda","year":"2017","unstructured":"Toyoda H, Chayama K, Suzuki F, et al. Efficacy and safety of glecaprevir\/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection. Hepatology. 2017. \nhttps:\/\/doi.org\/10.1002\/hep.29510\n\n[Epub ahead of print].","journal-title":"Hepatology"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-019-01016-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T23:31:38Z","timestamp":1594251098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-019-01016-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1007\/s12328-019-01016-3","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"assertion":[{"value":"7 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"Informed consent was obtained from the patient in our study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}